MORE►
OncoNano
Carter Inc. during a move at Pegasus Park in Dallas. [Photo: Carter Inc.]
From Research Labs to Operating Rooms, Dallas-Based Carter Inc. Packs Up Success for Critical Relocations
by Nicole Ward, DRC Data Journalist | Aug 14, 2024
Carter Inc. aims to be the first call for both corporate and high-stakes biotech relocations, working to keep transitions smooth and operations on track.
by Lance Murray |
Nov 3, 2022
Now in its fourth year, the program from Dallas Innovates and D CEO honors 68 disruptors and trailblazers driving a new vision for innovation in North Texas.
Finalists will be recognized in the January/February issue of D CEO magazine and online at DallasInnovates.com. Winners will be revealed at an exclusive awards event in January.
MORE►
by Lance Murray |
Jun 10, 2022
In this week’s roundup of hires, promotions, and accolades in North Texas, you’ll also find news from Catalyze Dallas, Flexport, Oceans Healthcare, Costar Technologies, TXOne Networks, North Texas Food Bank, Holt Lunsford Commercial, and others.
MORE►
by Dave Moore |
May 24, 2022
"It takes time" to establish a track record, Jorge Varela says, and the region is starting to see a series of biotech successes and spinoffs that will elevate the region's profile as a biotech hub.
According to a panel of experts at Urban Land Institute's 2022 spring meeting, here are factors drawing biotech to DFW.
According to a panel of experts at Urban Land Institute's 2022 spring meeting, here are factors drawing biotech to DFW.
MORE►
OncoNano CEO Martin Driscoll [Photo: OncoNano]
OncoNano Expands Research Collaboration With UT Southwestern to Advance New Cancer Therapies
by David Seeley | Sep 22, 2021
Southlake-based OncoNano Medicine uses pH-sensitive nanoparticle technology to "light up" cancer for real-time surgical imaging. The multi-year collaboration will seek to uncover new cancer therapies that can benefit from OncoNano's technology.
OncoNano raised $50 million in Series B funding in June.
MORE►
by Alex Edwards |
Jun 17, 2021
The investment was led by Advantech Capital, a PE fund based in China that focuses on TMT, pharmaceuticals, and healthcare. This combined with the support from the Cancer Prevention and Research Institute of Texas (CPRIT), which granted OncoNano $9.97 million last year, will support Phase 3 clinical trials for the biotech's technology that can diagnose and treat cancer with high specificity.
MORE►
by Quincy Preston |
Aug 20, 2020
OncoNano Medicine, a spinout of University of Texas Southwestern, uses pH as a biomarker to detect metastatic cancer. Its technology, which visualizes a tumor, could be a gamechanger.
MORE►
by Jeff Bounds |
Jan 22, 2020
Here are notable organizations that veterans of the eye care giant have started or hold executive positions in.
MORE►
[Illustration: Antiv3D via iStock]
Follow the Money: OncoNano Series A Funding Reaches $35.4M; ECi Acquires UK Software Reseller
by Lance Murray | Jul 18, 2019
You’ll find news about more than $6.4B in deals. Trive Capital, Cresco Capital Partners, Prologis, WatchGuard, Rent-A-Center, Comstock Resources, Covey Park Energy, Interstate Restoration, and Temperature Control Systems also are included in this roundup of funding, merger, and acquisition activity in North Texas.
MORE►
by Lance Murray |
May 2, 2019
You’ll also find news about OncoNano, Mark Cuban, Revint Solutions, Payment Partners, ESO, and eCore Software in this roundup of funding, merger, and acquisition activity involving investors and companies with ties to North Texas.
MORE►
Follow the Money: OncoNano Closes $11.7M Round, Perot Jain Backs 2 Startups, BP Energy Raising $475M
by Lance Murray |
May 17, 2018
From cancer-fighting compounds to startups transforming the retail experience, here's a look at recent funding involving companies and firms with North Texas ties.
MORE►
by Lance Murray |
May 23, 2016
A researcher at UT Dallas has created catalyst materials that could extend battery lives in cellphones and vehicles.
MORE►
